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SUMMARY One hundred and seven patients with colorectal carcinoma were examined for their immune response to autologous tumour. Patient leucocyte migration inhibition by tumour antigen, migration inhibition of normal subject's leucocytes by patient's serum, and the assessment of lymphocyte invasion of the tumour specimen were used to measure the immune response. Forty-one and 51 % of patients were immune by leucocyte migration inhibition and tumour invasion by lymphocytes respectively. The immune patients had a survival advantage at three years on Chisquared analysis. Patients whose serum contained a factor that inhibited the migration of leucocytes obtained from normal individuals had a diminished survival prognosis. The donors of these sera had a 50 % chance of dying or of developing recurrent disease. These same individuals represented 30 % of all those tested by this method. The immune patients included the sera donors as a subgroup who, if excluded from the life table analysis, left a group of immune subjects who had very superior survival features.
The prognosis for patients with carcinoma of the colon has remained unchanged for the past two or three decades. Those individuals who can be offered curative surgery have a better survival (Slaney, 1971; Gill and Morris, 1978) . In addition, patients with 'early' lesions, Dukes stage A or B, and those who can be offered an anterior instead of an abdominoperineal resection enjoy a survival advantage (Gill and Morris, 1978) .
Despite these clinical prognostic observations, the final denominator determining survival is the host tumour interaction. This response is best seen in the tumour invasion profile, which can be used to predict the likely disease progression (Montessori and Donald, 1978) . This profile is possibly an expression of tumour factors like their ability to secrete mucus or their histological grade (Grinnell, 1939) and the host immunological reaction to the tumour. Previously we have examined the host immune response to carcinoma of the colon by measuring the lymphocyte invasion of the tumour specimen (Watt and House, 1978) and the leucocyte migration inhibition response of patient's leucocytes to their tumour (House et al., 1975) . The present study extends these observations.
TUMOUR SPECIMENS
The resected specimen was collected in saline and portions of it prepared as tissue homogenates (House et al., 1975) . These homogenates, one of tumour and one of normal mucosa, were used in tissue culture as antigen at 300 ,ug/ml by protein estimation. A previous trial in which varying antigen concentrations had been used in culture showed that this quantity of antigen did not cause non-specific toxic inhibition of migration. The unused homogenate was stored at -25°C in small aliquots until required.
The remaining portion of the operative specimen was formalin fixed and prepared for routine histological examination.
METHOD OF LEUCOCYTE MIGRATION INHIBITION
Twenty millilitres of heparinised venous blood were collected in the first and subsequent postoperative weeks from the patients and matched controls. The majority of the observations were made in the first 12 months after surgery when the patients were most readily available. The collected blood samples were prepared in leucocyte migration inhibition cultures in a manner previously described (House et al., 1975) . The complete buffy coat of the collected blood was used in these assays.
The control subjects cell pellet was divided in half and one half incubated in the patient's serum at 37°C for 30 minutes and then washed and placed in leucocyte migration cultures.
The culture chambers were arranged so that there were five control cultures containing tissue culture medium (TCM) and 10% foetal calf serum (FCS) (Metcalf, 1974) . Patient survival at three years was also compared by Chisquared analysis.
Results

EVALUATION OF LEUCOCYTE MIGRATION ASSAYS
The migration inhibition assay demonstrated that the patient and control subjects behaved differently when tumour or normal colon antigen were in culture. The tumour patients responded to tumour antigen more often and to a greater level of inhibition than did the control subjects' cells. The difference in (Fig. 1) . If a stricter (Fig. 3) . 
Discussion
Leucocyte migration inhibition has been used to define immunity in a number of pathological conditions (Sorborg and Bendixen, 1967; Elias and Elias, 1975; Imai et al., 1977) . These authors have all used 20 % migration inhibition to indicate immunity. The mean response of the patients to normal colon antigen and the control subjects to both tumour and normal colon antigen indicated that all those tested were not immune to these antigens. However, the standard deviation from the mean placed some of the recorded values within the 20% inhibition immune range, which suggested that the cell donor may have been immune to the particular test antigen.
There were a number of alternative explanations for this immune response. Particulate matter in the culture system may have been a cause of false positive leucocyte migration inhibition, but others have shown that particulate antigens are more effective in the migration assay than soluble ones (Gorski, 1974) . In addition, the reaction will not function in the absence of lymphocytes (Fimmel, 1975) , which would suggest that the response is specifically directed toward the specific antigen.
Common antigens between the tumour and normal colon preparations of cellular or contaminant bacterial origin may have been responsible for some false responses. However, care was taken in the antigen preparation to minimise these possibilities and they seem unlikely, for within the tumour group few patients responded to normal colon antigen. This was verified by the clear statistical distinction between the mean migration inhibition values obtained when the results for the two antigens were compared: P <0005. There also was a statistical difference between the results of the patient and control subjects when both the tests with tumour and colon antigen were analysed. However, the difference between the two groups with colon antigen was small and so was probably not of biological significance.
Additional explanation is proffered in the control subject tests. There was no statistically significant difference between the control subject responses to tumour or normal colon antigen. The occasional positive normal subject immune response could have been due to a number of variants, allogeneic differences between the test antigens and the control individual, presensitisation to possible contaminant bacterial antigens, or an occult neoplasm in the leucocyte donor. Those few subjects who have had positive responses are being screened for the latter possibility. Cochrum et al. (1977) have shown that the first explanation is possible. These authors demonstrated that leucocyte migration inhibition by HLA antigens correlates with mixed lymphocyte culture defined allogeneic differences.
The mean migration index for the tumour patients to their tumour antigen was within the immune range. Sixty-five (61 %) of our patient group were immune at 20% of migration inhibition by this antigen. This percentage of immune patients is similar to that reported by Guillou and Giles (1973) but is lower than that reported by Elias and Elias (1975) . This level of migration inhibition as a criteria for immunity in this study was not discriminatory without qualification. The survival of this immune group was not significantly different from the non-immune group.
Those patients who were immune by migration inhibition of 29% by tumour antigen were clearly distinct from the control subjects. The immune group of patients was reduced to 44 (41 %). This number was similar to that previously reported by us (House et al., 1975) and similar to that found in carcinoma of the breast (Stein at al., 1976) . The stricter criteria were also discriminatory in survival terms. This immune group of patients enjoyed a survival advantage that was statistically significant at three years.
The immune patients in this study were found to JV - have tumours that spanned all the histological grades. However, there were proportionally more patients in the immune group who had welldifferentiated neoplasms. This may have been a reflection of a well-developed host tumour interaction but the relatively poor crude survival (50% mortality) among these individuals might suggest the contrary. At the time of review there were 16 (39 %) deaths due to carcinoma in the immune subjects and 24 (38%) in the non-immune group. The average survival for the dead was 518 and 488 days respectively. The immune patients were found among those grouped in each of the Dukes stages. The total number contained immune and non-immune subjects in equal proportions of stage A, but 50% and 25 % more non-immune stage B and C individuals.
However, within the immune group, there was a greater percentage of stage A patients (51 %) than those classified Dukes C (39 %). This compares with similar percentages of each stage in the non-immune subjects. This distribution was similar to that found by Rao et al. (1977) but at variance with that reported by Jubert et al. (1977) and Elias et al. (1977) .
The results in this study suggested that it is possible to passively confer immunity on normal subjects cells by incubating them in patient's serum. The donor of such a serum did not appear to suffer a detrimental consequence. However, the donor of a serum that spontaneously inhibited the migration of normal leucocytes in the absence of the immunising tumour antigen did have an altered prognosis. These donors had a 50 % chance of developing recurrence or dying of their disease. Others have reported that serum factors had an immune suppression effect in carcinoma of the breast (Whittaker et al., 1971) , colorectal cancer (Guillou and Giles, 1973) , and melanoma (Cochran et al., 1976 Pryce, 1966) , stomach (Black et al., 1971) and colon (Murray et al., 1975) . The findings in this study confirm these results. Lymphocyte infiltration at the periphery of the tumour was associated with a statistically better prognosis at three years and the survival curve suggested that this would be maintained in later years. 
